RHONDA HOLT: Open Payments
NPI 1366930323 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$632 in 30 payments from 5 companies in 2025. Trend: 2023 $196 · 2024 $233 · 2025 $632
Food & beverage: $587Education: $45
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $367 |
| Lilly USA, LLC | 5 | $114 |
| Novo Nordisk Inc | 4 | $63 |
| Viatris Specialty LLC | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
Products named: CAPLYTA, YUPELRI, MOUNJARO, Ozempic, BREZTRI, ZEPBOUND, Rybelsus.
Industry payments across TX — which companies pay providers there.
